Assertio (NASDAQ:ASRT - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of...
MarketBeat·5d ago
More News
Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates
Assertio (ASRT) delivered earnings and revenue surprises of +237.50% and +83.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
Assertio Reports Third Quarter 2025 Financial Results
Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients...
Business Wire·6d ago
Earnings Outlook For Assertio Holdings
read more...
Benzinga·10d ago
Xeris Biopharma (XERS) Reports Break-Even Earnings for Q3
Xeris Biopharma (XERS) delivered earnings and revenue surprises of -100.00% and +0.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11d ago
New Strong Sell Stocks for September 23rd
ATS, ASRT and DBVT have been added to the Zacks Rank #5 (Strong Sell) List on September 23, 2025.
Zacks·2mo ago
New Strong Sell Stocks for September 19th
ASRT, CE and ARR have been added to the Zacks Rank #5 (Strong Sell) List on September 19, 2025.
Zacks·2mo ago
New Strong Sell Stocks for September 16th
ASRT, ARMN and AMRZ have been added to the Zacks Rank #5 (Strong Sell) List on September 16, 2025.
Zacks·2mo ago
New Strong Sell Stocks for August 26th
ASRT, BSM and JJSF have been added to the Zacks Rank #5 (Strong Sell) List on August 26, 2025.
Assertio (ASRT) delivered earnings and revenue surprises of -70.00% and +4.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?